Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

To Compare the Effect of a Subcutaneous Canakinumab Administration to Placebo in Patients With Impaired Glucose Tolerance or Patients With Type 2 Diabetes With Differing Baseline Diabetes Therapies

Novartis · 2010
ClinicalTrials.gov · Datasets · License: Public Domain · 2010
Open Source ↗
metabolic-syndrometype-2-diabetes-mellitus
type 2 diabetes mellitus, impaired glucose tolerance, canakinumab, pre diabetic, glucose intolerant, oral anti diabetic medication, insulin treatment, metabolic syndrome, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 897510
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.